• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Expansion

Compass Partners' Rodenstock completes €75m capital increase

  • Harriet Matthews
  • Harriet Matthews
  • 16 June 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Ophthalmology company Rodenstock, a portfolio company of Compass Partners, has announced the completion of an equity capital increase of up to €75m from its existing investors.

The capital increase will support the company's liquidity needs and capital base, Rodenstock said in a statement, and will also be used to support its growth.

Compass Partners had planned to sell Rodenstock and mandated Jefferies to do so in February 2020, according to Unquote sister publication Mergermarket, but the GP put the sale on hold in May 2020. The exit is expected to be delayed until market conditions improve as the company is not in financial distress, according to sources cited by Mergermarket.

Rodenstock

  • DEAL:

    Expansion

  • VALUE:

    €75m

  • LOCATION:

    Munich

  • SECTOR:

    Specialised consumer services

  • FOUNDED:

    1877

  • TURNOVER:

    €450m

  • EBITDA:

    €103m

  • STAFF:

    4,900

Compass Partners bought a majority stake in Rodenstock from Bridgepoint in 2016 and completed its investment in the company in 2018 in a €100m transaction for three Bridgepoint assets, backed by Glendower Capital, which saw Compass acquire the remaining 20% stake in Rodenstock. Bridgepoint had acquired Rodenstock from Permira in January 2007.

Previous funding
Rodenstock completed a refinancing in June 2019 comprising a €395m term loan and a €20m revolving credit facility issued by JP Morgan as sole lead arranger.

S&P Global downgraded Rodenstock to B- stable in April 2020, responding to a projected decrease in demand in the wake of the closure of a number of retail stores due to the coronavirus outbreak.

Company
Munich-headquartered Rodenstock was founded in 1877 and sells glasses frames and lenses, as well as contact lenses. It employs 4,900 people, with production plants at 14 locations in 13 countries. It has distribution partners and sales offices in 85 countries.

In 2019, the company reported turnover of €450m and EBITDA of €103m, along with an EBITDA margin of 23%, marking a 2% increase on the 2018 margin. Rodenstock reported 2018 revenues of €425m and EBITDA of €91m.

People
Rodenstock
– Anders Hedegaard (CEO).
Compass Partners – Alister Wormsley (partner).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Expansion
  • DACH
  • Consumer
  • Germany

More on Expansion

Wealth managers and financial advisers
Blackstone takes minority stake in Groupe Premium

Deal values French wealth manager at EUR 1.15bn after earlier full exit attempt saw Eurazeo target EUR 1.5bn

  • Expansion
  • 31 July 2023
Risk and compliance management services
e-Attestations aims to triple size with new Keensight backing

Keensight is investing in the risk management platform via its EUR 1bn fifth fund, which closed in 2019

  • Expansion
  • 25 July 2023
Bolt-ons and buy-and-build platforms
The Bolt-Ons Digest - 3 July 2023

Unquote’s selection of the latest add-ons with Palatine's Anthesis, Nordic Capital's Regnology, Waterland's Janssen and more

  • Expansion
  • 03 July 2023
Valentina Vitali of Limerston Capital
GP Profile: Limerston Capital anticipates higher volume but more complex M&A as market steadies

UK-based GP is seeing dealflow driven by carve-outs and buy-and-build in a market where organic multiple arbitrage is no longer a given

  • GPs
  • 07 June 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013